Testing a new lung cancer drug alone and with chemotherapy

Plain-English translation of NCT07171606 on ClinicalTrials.gov ↗ · Source last updated December 2025 · Translation generated June 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

What is this trial?

This trial is testing a new medication called to see if it can help people with advanced non-small cell lung cancer. The study will test the medication in two ways: by itself and combined with standard chemotherapy drugs. Researchers want to find the right dose and see how well the treatment works and what side effects people experience.

Advanced lung cancer is difficult to treat, and current treatments don't work well enough for everyone. This trial exists to see whether this new medication could give patients another option for fighting their cancer, either on its own or as part of a combination approach.

Do you qualify?

You likely qualify if…

you are 18 years old or older
you have been diagnosed with advanced non-small cell lung cancer that has spread locally or to other parts of your body
you are in good enough health to handle the treatment (your doctor will assess this)
you are expected to live at least 3 more months
you are willing to sign an informed consent form showing you understand the trial

You likely don't qualify if…

you have lung cancer that has spread to your brain and is causing symptoms or cannot be controlled
you have severe side effects from previous cancer treatments (except hair loss or fatigue)
you have organ or bone marrow problems that make treatment unsafe
you are pregnant or breastfeeding
you are allergic to SSGJ-706 or cannot tolerate it

What participation looks like

You would receive the new medication at different dose levels, either alone or combined with chemotherapy, depending on which treatment group you're assigned to. You'll have regular clinic visits to receive your treatment and have blood tests and scans to check how you're responding and monitor for side effects. The trial involves about 240 participants total, and your doctors will track how well the medication is working for your specific cancer.

AI-generated summary from trial data · Jun 9, 2026 · Not medical advice

Trial locations(1 site)

China

Institute of The Shanghai Pulmonary Hospital, Shanghai